Literature DB >> 32188612

Unusual case of antiphospholipid syndrome presenting as adrenal insufficiency.

Sanval Ahmed Warriach1, Mohamad Mustafa2, Denis O'Keeffe3, Michael Watts2.   

Abstract

A 64-year-old man presented to the emergency department with generalised fatigue and dizzy spells. His background history includes a previous admission with right leg deep vein thrombosis, provoked by pneumonia. Laboratory results showed evidence of hyponatremia and hyperkalaemia. A synacthen test was performed that indicated hypoadrenalism. CT of his abdomen revealed enlarged adrenal glands bilaterally. Adrenal antibodies and positron emission tomography (PET) scan were performed to assess the cause of enlarged adrenals. PET scan showed no evidence of increased uptake. Adrenal antibodies were found to be negative. Tuberculous (TB) adrenalitis was the principle differential diagnosis. TB QuantiFERON was strongly positive. Following 9 months of TB treatment, surveillance CT scan indicated a significant reduction in adrenal gland size. However, subsequent events culminated in a retrospective review of CT scans questioning the initial clinical diagnosis and suggesting that the observed adrenal gland enlargement was secondary to bilateral adrenal infarction and haemorrhage. Equally, the subsequently observed marked reduction in adrenal gland size was not secondary to an assumed response to TB therapy, but rather the sequela of infracted atrophied adrenal glands, as a manifestation of the underlying antiphospholipid syndrome (APS). The case highlights the importance of recognising adrenal insufficiency in patients with a history of APS. It also illustrates the role of multidisciplinary meetings in the management of such complex cases. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  adrenal disorders; haematology (incl blood transfusion); tuberculosis

Mesh:

Substances:

Year:  2020        PMID: 32188612      PMCID: PMC7078771          DOI: 10.1136/bcr-2019-233631

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Investigation of false-positive results given by the QuantiFERON-TB Gold In-Tube assay.

Authors:  Madeline Slater; Julie Parsonnet; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

2.  False-positive QuantiFERON TB-Gold test due to Mycobacterium gordonae.

Authors:  Kiran Gajurel; Aruna K Subramanian
Journal:  Diagn Microbiol Infect Dis       Date:  2015-10-28       Impact factor: 2.803

3.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

4.  Venous infarction of the adrenal glands.

Authors:  B Fox
Journal:  J Pathol       Date:  1976-06       Impact factor: 7.996

Review 5.  Acute adrenal failure as the heralding symptom of primary antiphospholipid syndrome: report of a case and review of the literature.

Authors:  Fabio Presotto; Francesca Fornasini; Corrado Betterle; Giovanni Federspil; Marco Rossato
Journal:  Eur J Endocrinol       Date:  2005-10       Impact factor: 6.664

Review 6.  Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant).

Authors:  Claudia Mendoza-Pinto; Mario García-Carrasco; Ricard Cervera
Journal:  Curr Rheumatol Rep       Date:  2018-08-20       Impact factor: 4.592

7.  Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Jean-Charles Piette; Josep Font; Munther A Khamashta; Yehuda Shoenfeld; María Teresa Camps; Soren Jacobsen; Gabriella Lakos; Angela Tincani; Irene Kontopoulou-Griva; Mauro Galeazzi; Pier Luigi Meroni; Ronald H W M Derksen; Philip G de Groot; Erika Gromnica-Ihle; Marta Baleva; Marta Mosca; Stefano Bombardieri; Frédéric Houssiau; Jean-Christophe Gris; Isabelle Quéré; Eric Hachulla; Carlos Vasconcelos; Beate Roch; Antonio Fernández-Nebro; Marie-Claire Boffa; Graham R V Hughes; Miguel Ingelmo
Journal:  Arthritis Rheum       Date:  2002-04

8.  Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.

Authors:  R Cervera; R Serrano; G J Pons-Estel; L Ceberio-Hualde; Y Shoenfeld; E de Ramón; V Buonaiuto; S Jacobsen; M M Zeher; T Tarr; A Tincani; M Taglietti; G Theodossiades; E Nomikou; M Galeazzi; F Bellisai; P L Meroni; R H W M Derksen; P G D de Groot; M Baleva; M Mosca; S Bombardieri; F Houssiau; J-C Gris; I Quéré; E Hachulla; C Vasconcelos; A Fernández-Nebro; M Haro; Z Amoura; M Miyara; M Tektonidou; G Espinosa; M L Bertolaccini; M A Khamashta
Journal:  Ann Rheum Dis       Date:  2014-01-24       Impact factor: 19.103

Review 9.  The antiphospholipid syndrome: from pathophysiology to treatment.

Authors:  Simone Negrini; Fabrizio Pappalardo; Giuseppe Murdaca; Francesco Indiveri; Francesco Puppo
Journal:  Clin Exp Med       Date:  2016-06-22       Impact factor: 3.984

10.  A case report: Addison disease caused by adrenal tuberculosis.

Authors:  Moh Adi Soedarso; K Hery Nugroho; K A Meira Dewi
Journal:  Urol Case Rep       Date:  2018-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.